HemoBioTech
HemoBioTech Indicates ''HEMOTECH'' Commercial Development Strategy is Unaffected by Recent FDA/NIH Workshop on Blood Substitutes
Published in Medical Letter on the CDC and FDA, June 8th, 2008
HemoBioTech (OTC Bulletin Board:HMBT.OB)(www.hemobiotech.com)- announced that its blood substitute, HemoTech, was not part of the National Institute of Health (NIH) safety analysis of the free hemoglobin-based oxygen carrying solutions that was recently published in JAMA, 2008;299(19); This meta-analysis reported a 30 percent higher risk of death overall for patients who received transfusions using the first-generation blood substitute products developed by five different companies; Baxter, Hemosol, Biopure, Northfield and Sangart. According to the study, the risk of heart attack nearly tripled in the groups receiving these...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cardiovascular Disease
When It comes to Matters of the Heart, Almonds Are a Multi-Tasker - Colon Cancer
New findings in colon cancer described from University of Texas - Life Sciences
Study results from H.K. Park et al provide new insights into life sciences - Life Sciences
Study results from M. Brandt and colleagues in the area of life sciences published - Asthma Clinical Trial
Research from D.G. Woodside and colleagues has provided new data on asthma clinical trial - Humanized Antibodies
Findings from University of Debrecen, Medical and Health Science Center provide new insights into humanized antibodies - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
